Invention Grant
US07727533B2 Serpentine transmembrane antigens expressed in human cancers and uses thereof
有权
在人类癌症中表达的蛇纹石跨膜抗原及其用途
- Patent Title: Serpentine transmembrane antigens expressed in human cancers and uses thereof
- Patent Title (中): 在人类癌症中表达的蛇纹石跨膜抗原及其用途
-
Application No.: US10857785Application Date: 2004-05-28
-
Publication No.: US07727533B2Publication Date: 2010-06-01
- Inventor: Daniel E. Afar , Rene S. Hubert , Arthur B. Raitano , Douglas Saffran , Steven Chappell Mitchell
- Applicant: Daniel E. Afar , Rene S. Hubert , Arthur B. Raitano , Douglas Saffran , Steven Chappell Mitchell
- Applicant Address: US CA South San Francisco
- Assignee: Genentech, Inc.
- Current Assignee: Genentech, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Arnold & Porter LLP
- Agent Bettie Barnes, Esq.; Ginger R. Dreger, Esq.
- Main IPC: A61K39/00
- IPC: A61K39/00

Abstract:
Described is a family of cell surface serpentine transmembrane antigens. Two of the proteins in this family are expressed in the prostate, as well as in prostate cancer, and thus members of this family have been termed “STEAP” (Six Transmembrane Epithelial Antigen of the Prostate). Four particular human STEAPs are described and characterized herein. The human STEAPs exhibit a high degree of structural conservation among them but show no significant structural homology to any known human proteins. The prototype member of the STEAP family is STEAP-1, which appears to be a type IIIa membrane protein. STEAP-1 is a 339 amino acid protein. STEAP-1 protein expression is maintained at high levels across various stages of prostate cancer. Moreover, STEAP-1 is highly over-expressed in certain other human cancers.
Public/Granted literature
- US20040219162A1 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof Public/Granted day:2004-11-04
Information query